1.17

0.85% -0.01

After Hours: 1.17

Mindwalk Holdings Corp (HYFT)

Overview News Price History Discussions Forecast

Mindwalk Holdings Corp stock is traded at $1.17, with a volume of 207.44K. It is down -0.85% in the last 24 hours and down -17.02% over the past month. MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Previous Close:

$1.18

Open:

$1.18

24h Volume:

207.44K

Relative Volume:

0.46

Market Cap:

$54.63M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-1.68%

1M Performance:

-17.02%

6M Performance:

-39.69%

1Y Performance:

+0.00%

1-Day Range:

$1.14

$1.239

1-Week Range:

$1.05

$1.25

52-Week Range:

$1.05

$2.99

Mindwalk Holdings Corp Stock (HYFT) Company Profile

Name

Mindwalk Holdings Corp

Sector

Healthcare (1108)

Industry

Biotechnology (618)

Phone

Address

Employee

102

Twitter

Next Earnings Date

Latest SEC Filings

HYFT's Discussions on Twitter

Compare HYFT vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HYFT Mindwalk Holdings Corp	1.17	55.10M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	460.82	121.40B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	764.93	83.25B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	728.11	46.39B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	320.51	43.41B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	292.94	33.09B	5.36B	287.73M	924.18M	2.5229

Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-22	Initiated	H.C. Wainwright	Buy
Oct-25-21	Initiated	The Benchmark Company	Buy

Mindwalk Holdings Corp Stock (HYFT) Latest News

Mar 04, 2026

HYFT Forecast, Price Target & Analyst Ratings | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill

Mar 04, 2026

HYFT SEC FilingsMindWalk Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026

Mar 02, 2026

MindWalk Holdings to Report Q3 2026 Earnings - National Today

Mar 02, 2026

MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - 01net

Mar 02, 2026

MindWalk Sets March 12 Date to Report Q3 2026 Results and Host Earnings Webcast - TipRanks

Mar 02, 2026

Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire

Jan 27, 2026

MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks

Jan 27, 2026

MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance

Jan 27, 2026

Jan 26, 2026

MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai

Jan 26, 2026

Jan 22, 2026

HYFT Forecast — Price Prediction for 2026. Should I Buy HYFT? - Intellectia AI

Jan 22, 2026

After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛

Jan 22, 2026

Jan 15, 2026

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace

Jan 15, 2026

Jan 14, 2026

Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com

Jan 14, 2026

Jan 12, 2026

Scientists trace a hidden flu constraint across strains and hosts - Stock Titan

Jan 12, 2026

REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Yahoo Finance

Jan 12, 2026

Jan 11, 2026

MindWalk (HYFT) Makes Progress in Influenza Research with Key Di - GuruFocus

Jan 11, 2026

Jan 10, 2026

MindWalk Holdings Corp. Advances Universal Influenza Program with A Breakthrough Functional Insight - marketscreener.com

Jan 10, 2026

Jan 09, 2026

MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - 01net

Jan 09, 2026

MindWalk Unveils Cross-Strain Functional Constraint to Advance Universal Flu Vaccine Effort - TipRanks

Jan 09, 2026

MindWalk : Charter of the Audit Committee of the Board of Directors - marketscreener.com

Jan 09, 2026

MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce - Sahm

Jan 09, 2026

Jan 06, 2026